Samoa Digital Library

Lymphatic filariasis elimination in American Samoa: evaluation of molecular xenomonitoring as a surveillance tool in the endgame

Show simple item record

dc.contributor.author Lau, Colleen L
dc.contributor.author Won, Kimberly Y
dc.contributor.author Lammie, Patrick J
dc.contributor.author Graves, Patricia M
dc.date.accessioned 2021-12-01T21:15:43Z
dc.date.available 2021-12-01T21:15:43Z
dc.date.issued 2016
dc.identifier.citation Lau CL, Won KY, Lammie PJ, Graves PM (2016) Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame. PLoS Negl Trop Dis 10(11): e0005108. doi:10.1371/journal. pntd.0005108 en_US
dc.identifier.uri ${sadil.baseUrl}/handle/123456789/962
dc.description 16 p. ill : graphs, tables ; 28cm en_US
dc.description.abstract The Global Programme to Eliminate Lymphatic Filariasis has made significant progress toward interrupting transmission of lymphatic filariasis (LF) through mass drug administration (MDA). Operational challenges in defining endpoints of elimination programs include the need to determine appropriate post-MDA surveillance strategies. As humans are the only reservoirs of LF parasites, one such strategy is molecular xenomonitoring (MX), the detection of filarial DNA in mosquitoes using molecular methods (PCR), to provide an indirect indicator of infected persons nearby. MX could potentially be used to evaluate program success, provide support for decisions to stop MDA, and conduct post-MDA surveillance. American Samoa has successfully completed MDA and passed WHO recommended Transmission Assessment Surveys in 2011 and 2015, but recent studies using spatial analysis of antigen (Ag) and antibody (Ab) prevalence in adults (aged 18 years) and entomological surveys showed evidence of possible ongoing transmission. This study evaluated MX as a surveillance tool in American Samoa by linking village-level results of published human and mosquito studies. Of 32 villages, seropositive persons for Og4C3 Ag were identified in 11 (34.4%), for Wb123 Ab in 18 (56.3%) and for Bm14 Ab in 27 (84.4%) of villages. Village-level seroprevalence ranged from 0±33%, 0±67% and 0±100% for Og4C3 Ag, Wb123 Ab and Bm14 Ab respectively. PCR-positive Aedes polynesiensis mosquitoes were found in 15 (47%) villages, and their presence was significantly associated with seropositive persons for Og4C3 Ag (67% vs 6%, p<0.001) and Wb123 Ab (87% vs 29%, p = 0.001), but not Bm14 Ab. In villages with persons seropositive for Og4C3 Ag and Wb123 Ab, PCRpositive Ae. polynesiensis were found in 90.9% and 72.2% respectively. In villages without seropositive persons for Og4C3 Ag or Wb123 Ab, PCR-positive Ae. polynesiensis were also absent in 94.1% and 70.6% of villages respectively. Our study provides promising evidence to support the potential usefulness of MX in post-MDA surveillance in an Aedes transmission area in the Pacific Islands setting. en_US
dc.language.iso en en_US
dc.publisher PLOS Neglected Tropical Diseases en_US
dc.relation.ispartofseries Article in PLOS Neglected Tropical Diseases;Volume 10 Issue 11
dc.subject Filariasis - prevention - American Samoa en_US
dc.subject Mosquitoes as carriers of disease en_US
dc.subject Parasitic diseases en_US
dc.title Lymphatic filariasis elimination in American Samoa: evaluation of molecular xenomonitoring as a surveillance tool in the endgame en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Saili Sadil


Vaavaai

O a'u faʻamatalaga